메뉴 건너뛰기




Volumn 48, Issue 4, 1996, Pages 539-540

Neoadjuvant androgen-deprivation therapy prior to radical prostatectomy: Con

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN;

EID: 0030266943     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(96)00297-X     Document Type: Editorial
Times cited : (11)

References (5)
  • 1
    • 0025185669 scopus 로고
    • Radical prostatectomy for clinical T1-2N0M0 prostatic adenocarcinoma: Long term results
    • Paulson DF, Moul JW, and Walther PJ: Radical prostatectomy for clinical T1-2N0M0 prostatic adenocarcinoma: long term results. J Urol 144: 1180-1184, 1990.
    • (1990) J Urol , vol.144 , pp. 1180-1184
    • Paulson, D.F.1    Moul, J.W.2    Walther, P.J.3
  • 2
    • 0029059020 scopus 로고
    • Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxM0) prostate cancer: The Lupron Depot Neoadjuvant Prostate Cancer Study Group
    • Soloway MS, Sharifi R, Wajsman Z, McLeod D, Wood DP, and Puras-Baez A: Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxM0) prostate cancer: the Lupron Depot Neoadjuvant Prostate Cancer Study Group. J Urol 154: 424-428, 1995.
    • (1995) J Urol , vol.154 , pp. 424-428
    • Soloway, M.S.1    Sharifi, R.2    Wajsman, Z.3    McLeod, D.4    Wood, D.P.5    Puras-Baez, A.6
  • 3
    • 0000177452 scopus 로고    scopus 로고
    • Randomized prospective study: Radical prostatectomy alone vs. radical prostatectomy preceded by androgen block-age in cT2b prostate cancer
    • abstract 976
    • Soloway MS, Sharifi R, Wajsman Z, McLeod D, Wood D, Puras-Baez A, and the Lupron Depot Neoadjuvant Study Group: Randomized prospective study: radical prostatectomy alone vs. radical prostatectomy preceded by androgen block-age in cT2b prostate cancer (abstract 976). J Urol 155: 555A, 1996.
    • (1996) J Urol , vol.155
    • Soloway, M.S.1    Sharifi, R.2    Wajsman, Z.3    McLeod, D.4    Wood, D.5    Puras-Baez, A.6
  • 5
    • 0042570883 scopus 로고    scopus 로고
    • Neoadjuvant cyproterone acetate therapy prior to radical prostatectomy reduces tumour burden and margin positivity without altering 6 and 12 month post-treatment PSA: Results of a randomized trial
    • abstract 356
    • Klotz LH, Goldenberg LS, Bullock MJ, Srigley JR, Lapalante S, and the Canadian Uro-Oncology Group: Neoadjuvant cyproterone acetate therapy prior to radical prostatectomy reduces tumour burden and margin positivity without altering 6 and 12 month post-treatment PSA: results of a randomized trial (abstract 356). J Urol 155: 399A, 1996.
    • (1996) J Urol , vol.155
    • Klotz, L.H.1    Goldenberg, L.S.2    Bullock, M.J.3    Srigley, J.R.4    Lapalante, S.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.